Parenteral Iron Therapy in Patients with Heart Failure in a Resource Constrained Setting In India - Our Experience.

Malav Darshan Jhala,Charan Lanjewar, Anirudha Pawar,Hetan Shah,Dhiraj Kumar,Prafulla Kerkar

The Journal of the Association of Physicians of India（2021）

引用 0|浏览6

暂无评分

摘要

Iron Deficiency is a major risk factor in Heart Failure including HFpEF and prevails in the younger population.Parenteral Iron Carboxymaltose followed by oral iron supplementation is effective in Heart Failure patients, especially in HFpEF. Functional capacity and NYHA status appear to be the time tested markers for Iron repletion.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要